Rallybio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-74.56	-66.65	-47.01	-26.45	-17.56
Depreciation & Amortization	0.15	0.17	0.11	0.06	0.03
Share-Based Compensation	10.92	9.5	3.65	0.7	0.19
Other Operating Activities	3.23	-0.3	-2.27	3.64	2.32
Operating Cash Flow	-60.27	-57.28	-45.53	-22.04	-15.03
Capital Expenditures	-0.01	-0.05	-0.33	-0.14	-0.19
Acquisitions	-2.25	-0.3	-2	-1.94	0
Change in Investments	29.92	-111.82	0	0	0
Investing Cash Flow	27.66	-112.17	-2.33	-2.07	-0.19
Share Issuance / Repurchase	0.28	51.77	86.2	145.21	0
Other Financing Activities	-0.14	-0.69	-3.23	-0.32	31.57
Financing Cash Flow	0.14	51.08	82.97	144.89	31.57
Net Cash Flow	-32.46	-118.38	35.1	120.78	16.35
Free Cash Flow	-60.28	-57.34	-45.87	-22.18	-15.21
Free Cash Flow Per Share	-1.49	-1.80	-1.80	-1.27	-8.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).